Catheter Precision Inc.

06/09/2025 | Press release | Distributed by Public on 06/09/2025 05:35

Material Event (Form 8-K)

Item 8.01 Other Events.
On June 5, 2025, the Catheter Precision, Inc. (the "Company") Board of Directors approved the issuance of a placement agent common stock purchase warrant (the "Warrant"), to acquire 257,143 shares of Company common stock at a purchase price of $0.5424 per share, to Ladenburg Thalmann & Co., Inc., as partial compensation for its services provided in connection with the Company's pipe financing that closed on May 12, 2025. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 13, 2025, which is incorporated by reference herein. The Warrant will become exercisable if and when the exercise is approved by the Company's stockholders, which approval the Company hopes to receive at its annual meeting of stockholders to be held on July 25, 2025. The Warrant will terminate on June 6, 2030. Neither the Warrant nor the shares of common stock underlying it have been registered under the Securities Act of 1933, as amended. A copy of the Warrant is filed as Exhibit 4.1 hereto and is incorporated herein by reference.
Catheter Precision Inc. published this content on June 09, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 09, 2025 at 11:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io